Event Description

Tackling High-Cost Cell & Gene Therapies, Employer Coverage Strategies & Misaligned Incentives

As the pharmacy benefit model and delivery of specialty drugs through the medical plan continues to miss the mark in a value-based solution, this annual forum will provide suggested actions and solutions for employers to disrupt the system and get results.

Through this day of education, you will:

Hear employer challenges and opportunities in driving accountability and vigilance in managing the high cost of cell and gene therapies
Understand leading solutions that work to catalyze employers to action
Identify plan design changes to make biosimilar utilization work
Explore the role of biomarker testing to minimize waste of biopharmaceuticals for the wrong patient
Get the latest update on state and federal policies and employer compliance requirements for pharmacy benefits

We look forward to seeing you in person* at this event! Please be assured we will conduct this program in a prudent, COVID-sensitive manner with careful attention to your health and safety. The specific protocols for attendance will be shared with registrants prior to the event.

*This program will also be available to be viewed virtually.

Registration Fees

Members $0
Employer Non-Members $25
Non-Members $100

HRCI Accreditation

This program is expected to be approved for 5 recertification credit hours through the HR Certification Institute (HRCI). For more information about certification or recertification, visit www.hrci.org. The use of the official seal confirms that this Program has met HRCI's criteria for re-certification credit pre-approval.

Employer Forum on Pharmacy Benefits & Specialty Drugs

Employer Forum on Pharmacy Benefits & Specialty Drugs

Tackling High-Cost Cell & Gene Therapies, Employer Coverage Strategies & Misaligned Incentives